![Limor Zur-Stoller](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Limor Zur-Stoller
Plus aucun poste en cours
Historique de carrière de Limor Zur-Stoller
Anciens postes connus de Limor Zur-Stoller
Sociétés | Poste | Début | Fin |
---|---|---|---|
ROSETTA GENOMICS LTD. | Directeur Financier/CFO | 06/11/2009 | 01/10/2010 |
G.F.C GREEN FIELDS CAPITAL LTD. | Directeur Financier/CFO | 19/04/2011 | - |
Public Communications Contact | 19/04/2011 | - | |
Gammacan International, Inc.
![]() Gammacan International, Inc. Medical SpecialtiesHealth Technology Gammacan International, Inc. operates as a life sciences company. The company focuses on the development of immunotherapy and related approaches to treat cancer. It also focuses on the use of intravenous immunoglobulin derived from human plasma provided by healthy donors to treat melanoma, prostate, and colon cancers. The company was founded on October 6, 1998 and is headquartered in Kiryat Ono, Israel. | Directeur/Membre du Conseil | 26/04/2011 | - |
Directeur Financier/CFO | 19/03/2008 | - | |
Treasurer | 19/03/2008 | - | |
RADVIEW SOFTWARE LTD. | Directeur Financier/CFO | - | - |
Public Communications Contact | 29/06/2009 | - |
Formation de Limor Zur-Stoller
Tel-Aviv University | Undergraduate Degree |
Statistiques
Internationale
Israël | 6 |
Opérationnelle
Director of Finance/CFO | 4 |
Public Communications Contact | 2 |
Director/Board Member | 1 |
Sectorielle
Health Technology | 3 |
Technology Services | 2 |
Consumer Services | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
Sociétés cotées | 3 |
---|---|
RADVIEW SOFTWARE LTD. | Technology Services |
ROSETTA GENOMICS LTD. | Health Technology |
G.F.C GREEN FIELDS CAPITAL LTD. | Finance |
Entreprise privées | 1 |
---|---|
Gammacan International, Inc.
![]() Gammacan International, Inc. Medical SpecialtiesHealth Technology Gammacan International, Inc. operates as a life sciences company. The company focuses on the development of immunotherapy and related approaches to treat cancer. It also focuses on the use of intravenous immunoglobulin derived from human plasma provided by healthy donors to treat melanoma, prostate, and colon cancers. The company was founded on October 6, 1998 and is headquartered in Kiryat Ono, Israel. | Health Technology |
- Bourse
- Insiders
- Limor Zur-Stoller
- Expérience